• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest.有丝分裂前期阻滞使结肠癌细胞对炎症细胞因子变得敏感。
Biochem Pharmacol. 2012 May 1;83(9):1217-28. doi: 10.1016/j.bcp.2012.01.024. Epub 2012 Jan 25.
2
Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels.联合组蛋白去乙酰化酶抑制剂伏立诺他与 Aurora 激酶抑制剂增强淋巴瘤细胞杀伤作用,并抑制 c-Myc、hTERT 和 microRNA 水平。
Cancer Res. 2011 Jun 1;71(11):3912-20. doi: 10.1158/0008-5472.CAN-10-2259. Epub 2011 Apr 18.
3
Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.辛二酰苯胺异羟肟酸(伏立诺他/泽珂)使原位植入BALB/c裸鼠体内的对肿瘤坏死因子相关凋亡诱导配体(TRAIL)耐药的乳腺癌细胞敏感化。
Mol Cancer Ther. 2009 Jun;8(6):1596-605. doi: 10.1158/1535-7163.MCT-08-1004. Epub 2009 Jun 9.
4
Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.伏立诺他联合治疗协同增强 Aurora 激酶抑制剂对人乳腺癌细胞的活性。
Breast Cancer Res Treat. 2012 Sep;135(2):433-44. doi: 10.1007/s10549-012-2171-9. Epub 2012 Jul 24.
5
Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.辛二酰苯胺异羟肟酸通过上调肺癌细胞中肿瘤坏死因子受体1增强肿瘤坏死因子-α的抗癌作用。
Oncotarget. 2017 Mar 14;8(11):17726-17737. doi: 10.18632/oncotarget.14628.
6
Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells.组蛋白去乙酰化酶抑制剂辛二酰苯胺异羟肟酸与TRAIL联合治疗对人乳腺癌细胞的协同作用。
Sci Rep. 2016 Jun 13;6:28004. doi: 10.1038/srep28004.
7
Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL.组蛋白去乙酰化酶抑制剂 SAHA 诱导的 cFLIP 无瘙痒/AIP4 依赖性蛋白酶体降解使乳腺癌细胞对 TRAIL 敏感。
Invest New Drugs. 2012 Apr;30(2):541-7. doi: 10.1007/s10637-010-9597-x. Epub 2010 Nov 25.
8
Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin.极光 B 通过磷酸化生存素赋予癌细胞对 TRAIL 诱导的细胞凋亡的抗性。
Carcinogenesis. 2012 Mar;33(3):492-500. doi: 10.1093/carcin/bgr298. Epub 2011 Dec 9.
9
Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.针对人结肠癌细胞中Aurora-A或Aurora-B激酶的抗癌药物疗效的决定因素。
Mol Cancer Ther. 2009 Jul;8(7):2046-56. doi: 10.1158/1535-7163.MCT-09-0323. Epub 2009 Jul 7.
10
STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.STI571 降低结肠癌细胞中 TRAIL 诱导的细胞凋亡:死亡受体激活 c-Abl 导致应激激酶依赖性细胞死亡。
J Biomed Sci. 2012 Mar 30;19(1):35. doi: 10.1186/1423-0127-19-35.

引用本文的文献

1
Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1.同时沉默 Aurora-A 和 UHRF1 通过调节 DNMT1 和 STAT1 的表达抑制结直肠癌细胞生长。
Int J Med Sci. 2021 Aug 5;18(15):3437-3451. doi: 10.7150/ijms.61969. eCollection 2021.
2
Efficient Activation of Apoptotic Signaling during Mitotic Arrest with AK301.使用AK301在有丝分裂停滞期间有效激活凋亡信号
PLoS One. 2016 Apr 20;11(4):e0153818. doi: 10.1371/journal.pone.0153818. eCollection 2016.
3
Aurora kinase A in gastrointestinal cancers: time to target.极光激酶A在胃肠道癌症中的作用:是时候进行靶向治疗了。
Mol Cancer. 2015 May 20;14:106. doi: 10.1186/s12943-015-0375-4.
4
Novel piperazine-based compounds inhibit microtubule dynamics and sensitize colon cancer cells to tumor necrosis factor-induced apoptosis.新型哌嗪类化合物抑制微管动力学并增强结肠癌对肿瘤坏死因子诱导凋亡的敏感性。
J Biol Chem. 2014 Jan 31;289(5):2978-91. doi: 10.1074/jbc.M113.499319. Epub 2013 Dec 12.
5
Identification of novel compounds that enhance colon cancer cell sensitivity to inflammatory apoptotic ligands.鉴定新型化合物,增强结肠癌细胞对炎症凋亡配体的敏感性。
Cancer Biol Ther. 2013 May;14(5):436-49. doi: 10.4161/cbt.23787. Epub 2013 Feb 1.
6
Hyperbaric oxygen preconditioning protects skin from UV-A damage.高压氧预处理可保护皮肤免受 UVA 损伤。
Cell Stress Chaperones. 2013 Jan;18(1):97-107. doi: 10.1007/s12192-012-0362-2. Epub 2012 Aug 3.

本文引用的文献

1
TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation.肿瘤坏死因子相关凋亡诱导配体(TRAIL)调节炎症性中性粒细胞凋亡,增强炎症消退。
J Leukoc Biol. 2011 Nov;90(5):855-65. doi: 10.1189/jlb.0211062. Epub 2011 May 11.
2
Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.药物抑制 Mdm2 会引发小鼠结肠肿瘤和人结肠癌细胞的生长停滞,并促进 DNA 断裂。
Mol Carcinog. 2012 May;51(5):363-78. doi: 10.1002/mc.20795. Epub 2011 May 6.
3
Inhibition of histone deacetylases in inflammatory bowel diseases.抑制炎症性肠病中的组蛋白去乙酰化酶。
Mol Med. 2011 May-Jun;17(5-6):426-33. doi: 10.2119/molmed.2011.00069. Epub 2011 Feb 22.
4
Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.肿瘤浸润性 T 细胞亚群、结直肠癌的分子变化与预后:队列研究与文献回顾
J Pathol. 2010 Dec;222(4):350-66. doi: 10.1002/path.2774.
5
Inhibition of histone deacetylase 3 produces mitotic defects independent of alterations in histone H3 lysine 9 acetylation and methylation.组蛋白去乙酰化酶 3 的抑制导致有丝分裂缺陷,而不依赖于组蛋白 H3 赖氨酸 9 乙酰化和甲基化的改变。
Mol Pharmacol. 2010 Sep;78(3):384-93. doi: 10.1124/mol.109.062976. Epub 2010 Jun 18.
6
Inflammation and colon cancer.炎症与结肠癌。
Gastroenterology. 2010 Jun;138(6):2101-2114.e5. doi: 10.1053/j.gastro.2010.01.058.
7
Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.调节性(FoxP3+)T 细胞肿瘤浸润是接受化疗或化疗免疫治疗的晚期结肠癌患者的有利预后因素。
J Immunother. 2010 May;33(4):435-41. doi: 10.1097/CJI.0b013e3181d32f01.
8
Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.肿瘤浸润淋巴细胞:结直肠癌患者生存的有趣参与者。
BMC Immunol. 2010 Apr 12;11:19. doi: 10.1186/1471-2172-11-19.
9
Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis.通过针对 APC 缺陷细胞的凋亡来预防结直肠癌。
Nature. 2010 Apr 15;464(7291):1058-61. doi: 10.1038/nature08871. Epub 2010 Mar 28.
10
Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden.Fas/CD95 缺陷型 ApcMin/+ 小鼠的肠道肿瘤负担增加。
PLoS One. 2010 Feb 5;5(2):e9070. doi: 10.1371/journal.pone.0009070.

有丝分裂前期阻滞使结肠癌细胞对炎症细胞因子变得敏感。

Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest.

机构信息

Department of Molecular and Cell Biology, 91 North Eagleville Road, University of Connecticut, Storrs, CT 06269, United States.

出版信息

Biochem Pharmacol. 2012 May 1;83(9):1217-28. doi: 10.1016/j.bcp.2012.01.024. Epub 2012 Jan 25.

DOI:10.1016/j.bcp.2012.01.024
PMID:22306067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3299870/
Abstract

Understanding how colon cancer cells survive within the inflammatory milieu of a tumor, and developing approaches that increase their sensitivity to inflammatory cytokines, may ultimately lead to novel approaches for colon cancer therapy and prevention. Analysis of a number of chemopreventive and therapeutic agents reveal that HDAC inhibitors are particularly adept at sensitizing colon cancer cells TNF or TRAIL mediated apoptosis. In vivo data are consistent with an interaction between SAHA and TNF in inducing apoptosis, as AOM-induced colon tumors express elevated levels of TNF and are more sensitive to SAHA administration. Cell cycle analysis and time-lapse imaging indicated a close correspondence between SAHA-induced prophase arrest and TNF or TRAIL-induced apoptosis. Prophase arrest induced by the Aurora kinase inhibitor VX680 likewise sensitized cells to TNF and TRAIL, with siRNA analysis pointing to Aurora kinase A (and not Aurora kinase B) as being the relevant target for this sensitization. We propose that agents that promote prophase arrest may help sensitize cancer cells to TNF and other inflammatory cytokines. We also discuss how circumvention of an early mitotic checkpoint may facilitate cancer cell survival in the inflammatory micro-environment of the tumor.

摘要

了解结肠癌细胞如何在肿瘤的炎症环境中存活,并开发出增加其对炎症细胞因子敏感性的方法,最终可能为结肠癌的治疗和预防提供新的方法。对许多化学预防和治疗药物的分析表明,HDAC 抑制剂特别擅长使结肠癌细胞对 TNF 或 TRAIL 介导的细胞凋亡敏感。体内数据与 SAHA 和 TNF 在诱导细胞凋亡中的相互作用一致,因为 AOM 诱导的结肠肿瘤表达高水平的 TNF,并且对 SAHA 给药更敏感。细胞周期分析和延时成像表明,SAHA 诱导的早前期阻滞与 TNF 或 TRAIL 诱导的细胞凋亡密切相关。Aurora 激酶抑制剂 VX680 诱导的早前期阻滞同样使细胞对 TNF 和 TRAIL 敏感,siRNA 分析表明 Aurora 激酶 A(而不是 Aurora 激酶 B)是这种敏感性的相关靶标。我们提出,促进早前期阻滞的药物可能有助于使癌细胞对 TNF 和其他炎症细胞因子敏感。我们还讨论了如何绕过早期有丝分裂检查点可能有助于癌细胞在肿瘤的炎症微环境中存活。